Tag Archives: specialty drug

Distribution

Limited Distribution Networks

Posted on by John Santilli

Limited Distribution Networks growth continues as Specialty Pharmacies compete to be chosen to distribute specialty pharmaceuticals. AMI’s report, Distribution Decision-Making for Specialty Drugs, found that Pharmaceutical manufacturers typically develop a product-specific distribution strategy dependent on company-specific criteria when bringing a new specialty drug to the market. Pharmaceutical manufacturers consider approximately 100-150 different specialty pharmacies (SPs) […]

Continue reading →
Specialty Drug

Specialty Drug Wave Hitting Medical and Pharmacy Plans Harder: Trends versus reliable benefit strategy to handle the impact through 2020?

Posted on by John Santilli

Specialty Drug Wave Hitting Medical and Pharmacy Plans Harder: Trends versus reliable benefit strategy to handle the impact through 2020?The U.S. now has two different markets resulting from implementation of the Affordable Care Act (ACA) and resultant trends. Related to specialty or biological drugs, public sector CMS’s forecast of drug spending is somewhat counterintuitive, given […]

Continue reading →
Specialty Drug

Proposed Changes to Rx Information Required in SBC

Posted on by John Santilli

Proposed Changes to Rx Information Required in SBC, Greg Judd, CEBS The American Medical Association (AMA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) are asking regulators to build more information about major medical plan drug coverage into the next revision of the Summary of Benefits and Coverage (SBC) and the Uniform Glossary (LifeHealthPro). […]

Continue reading →
Specialty Drug

Planning a Specialty Drug Strategy Through 2020

Posted on by John Santilli

Planning a Specialty Drug Strategy Through 2020 – Traditional approaches are not suited to managing the cost of specialty drug therapies By Gregory Judd, CEBS, and Randy Vogenberg, PhD  5/4/2015 (originally published by Society for Human Resource Management (SHRM))   The specialty drug tsunami is picking up strength and is about to come crashing down on […]

Continue reading →
Affordable Care Act, Dr. Randy Vogenberg, John Santilli, Market Intelligence, Trends

Key Strategic Trends that Impact Healthcare Decision-Making and Stakeholder Roles in the New Marketplace

Posted on by aprilgregory

By John Santilli, MBA, and F. Randy Vogenberg, PhD, RPh After the passage of the Affordable Care Act (ACA) in 2010, market changes beyond those already in play began to emerge. Traditional roles, responsibilities, and authority could now be tested or altered as a result of some sections of the ACA. One result is that […]

Continue reading →
Market Intelligence

2015 Pharmaceutical Market Trend Vol. I

Posted on by aprilgregory

While the Pharmaceutical Industry has been experiencing many shifts and changes, it is still a 21st Century Growth Industry based on the stats, facts and trends put out by Pharm Exec.More growth expected… Basic science of genomics and biology are leading to a discovery of treatments which are advanced by using the body’s own immune […]

Continue reading →
Market Report

Hepatitis C and Specialty Pharmacy Market

Posted on by aprilgregory

Express Scripts Plans a Specialty Drug Price War over new hepatitis C treatments reports a recent Bloomberg News story. The news follows the release of Gilead’s Sovaldi (sofosbuvir), which reportedly costs $1,000 per pill. Express Scripts projects that Hepatitis C drug trend will grow by 168% by 2015, so employers and health plan payers are […]

Continue reading →
Market Report

Contracting With Specialty Pharmacies (SPs) At Your Own Peril

Posted on by aprilgregory

How a company works with and contracts with SPs will have to be rethought as a result of the initial Department of Justice (DoJ) settlement with BioScrip and ongoing investigation of Novartis in their marketing practices. When Novartis launched Exjade, it created a limited distribution network, including BioScrip and two other specialty pharmacies selected by […]

Continue reading →